Literature DB >> 7000596

Matched glucose responses to insulin administered subcutaneously and intravenously. Evidence for subcutaneous inactivation of insulin.

R W Stevenson, T I Tsakok, J A Parsons.   

Abstract

A new technique of programmed intravenous insulin infusion at a series of decreasing rates has been used to imitate the magnitude and time course of biological responses obtained by the subcutaneous route. Groups of normal rats prepared with indwelling venous cannulae were injected subcutaneously with soluble porcine insulin, 0.4 U/kg. The pattern of the resulting hypoglycaemic response was subsequently matched by a 2-hour intravenous insulin infusion at rates decreasing stepwise from 0.3 to 0.05 U kg-1h-1. The total amount of insulin infused intravenously was only 50% of that required subcutaneously. In addition, subcutaneous or intravenous infusions of insulin at 0.05 U kg-1h-1 were given to two groups of rats from the same batch. When both infusions were continued until plateau responses were reached, a significantly greater lowering of plasma glucose was caused by the intravenous route. These results suggest that when insulin is given subcutaneously significant inactivation of the insulin occurs at or near the injection site.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000596     DOI: 10.1007/bf00276825

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  17 in total

1.  THE ROUTE OF INSULIN ADMINISTRATION IN THE MANAGEMENT OF DIABETES MELLITUS.

Authors:  J J NORA; D W SMITH; J R CAMERON
Journal:  J Pediatr       Date:  1964-04       Impact factor: 4.406

2.  Rate of clearance of insulin labelled with 131 I from the subcutaneous tissues in normal and diabetic subjects.

Authors:  C L JOINER
Journal:  Lancet       Date:  1959-05-09       Impact factor: 79.321

3.  A simple technique for continuous intravenous infusion in rats.

Authors:  R G Dalton; J L Touraine; T R Wilson
Journal:  J Lab Clin Med       Date:  1969-11

4.  Comparison on intravenous and subcutaneous insulin infusions in man.

Authors:  N Katsilambros; H Verykokidou; P Philipides; G Moiras; G K Daikos
Journal:  Lancet       Date:  1979-03-17       Impact factor: 79.321

5.  Mobilization of subcutaneously injected tritiated insulin in rats: effects of muscular exercise.

Authors:  M Berger; P A Halban; W A Muller; R E Offord; A E Renold; M Vranic
Journal:  Diabetologia       Date:  1978-08       Impact factor: 10.122

6.  Absorption kinetics of subcutaneously injected insulin. Evidence for degradation at the injection site.

Authors:  M Berger; P A Halban; L Girardier; J Seydoux; R E Offord; A E Renold
Journal:  Diabetologia       Date:  1979-08       Impact factor: 10.122

7.  Insulin infusion into the portal and peripheral circulations of unanaesthetized dogs.

Authors:  R W Stevenson; J A Parsons; K G Alberti
Journal:  Clin Endocrinol (Oxf)       Date:  1978-04       Impact factor: 3.478

8.  Glucose-lowering effect of insulin by different routes in obese and lean nonketotic diabetic patients.

Authors:  M N Shahshahani
Journal:  J Clin Endocrinol Metab       Date:  1978-07       Impact factor: 5.958

9.  Comparison of the effectiveness of various routes of insulin injection: insulin levels and glucose response in normal subjects.

Authors:  S M Guerra; A E Kitabchi
Journal:  J Clin Endocrinol Metab       Date:  1976-05       Impact factor: 5.958

10.  Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.

Authors:  J C Pickup; H Keen; J A Parsons; K G Alberti
Journal:  Br Med J       Date:  1978-01-28
View more
  10 in total

1.  The pharmacokinetics of, and humoral responses to, antigen delivered by microencapsulated liposomes.

Authors:  S Cohen; H Bernstein; C Hewes; M Chow; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

2.  Subcutaneous degradation of insulin.

Authors:  R W Stevenson
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

3.  Pharmacokinetic approach for reconstruction of predetermined plasma insulin profiles by continuous subcutaneous insulin infusion in depancreatized dogs.

Authors:  H Hirayama; Y Kasuya; T Kobayashi; T Itoh; A Yagishita; T Katakura; K Isono
Journal:  J Pharmacokinet Biopharm       Date:  1983-12

Review 4.  Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy.

Authors:  E W Kraegen; D J Chisholm
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

5.  Low subcutaneous degradation and slow absorption of insulin in insulin-dependent diabetic patients during continuous subcutaneous insulin infusion at basal rate.

Authors:  D J Chisholm; E W Kraegen; M J Hewett; S Furler
Journal:  Diabetologia       Date:  1984-08       Impact factor: 10.122

6.  In vitro studies on an antagonist of parathyroid hormone [Nle-8, Nle-18, Tyr-34]bPTH-(3-34)amide.

Authors:  D A Gray; J A Parsons; J T Potts; M Rosenblatt; R W Stevenson
Journal:  Br J Pharmacol       Date:  1982-06       Impact factor: 8.739

7.  Enhanced bioavailability of subcutaneously injected insulin by pretreatment with ointment containing protease inhibitors.

Authors:  M Takeyama; T Ishida; N Kokubu; F Komada; S Iwakawa; K Okumura; R Hori
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

8.  Evidence for insulin degradation by muscle and fat tissue in an insulin resistant diabetic patient.

Authors:  G F Maberly; G A Wait; J A Kilpatrick; E G Loten; K R Gain; R D Stewart; C J Eastman
Journal:  Diabetologia       Date:  1982-10       Impact factor: 10.122

9.  Enhanced bioavailability of subcutaneously injected insulin coadministered with collagen in rats and humans.

Authors:  R Hori; F Komada; S Iwakawa; Y Seino; K Okumura
Journal:  Pharm Res       Date:  1989-09       Impact factor: 4.200

10.  Interval between insulin injection and eating in relation to blood glucose control in adult diabetics.

Authors:  M E Lean; L L Ng; B R Tennison
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.